Skip to main content
Clinical Trials/NL-OMON45449
NL-OMON45449CompletedNot Applicable

Platelet activation and responsiveness in patients with acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) - AE-COPD reactivity

Academisch Medisch Centrum0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • In order to be eligible to participate in this study the COPD subjects must meet all of the following criteria:
  • * >40 years
  • * Spirometry confirmed diagnosis of COPD (i.e. post-bronchodilator FEV1/FVC < Lower limit of normal (LLN)).
  • * *10 pack years of smoking

Exclusion Criteria

  • * Use of anti-coagulation, aspirin or platelet function inhibitors, with the exception of cyclooxygenase inhibitors (e.g, carbasalate calcium, acetylsalicylic acid)
  • * Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases , systemic lupus erythematous (SLE)
  • * Malignancies

Investigators

Similar Trials